Correlative immunology from a study using ML NK cells as a cellular therapy for relapsed refractory acute myeloid leukemia (AML) identified a negative association between CD8α expression on donor ML NK cells and treatment outcome, such that expression of CD8α was higher on donor NK cells in patients experiencing treatment failure (24). The gene discussed is CD8A; the disease is acute myeloid leukemia.